267 related articles for article (PubMed ID: 17220956)
1. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
[TBL] [Abstract][Full Text] [Related]
2. Chronic fluvastatin treatment alters vascular contraction by inhibiting the Rho/Rho-kinase pathway.
Kansui Y; Fujii K; Goto K; Oniki H; Iida M
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):673-8. PubMed ID: 16895538
[TBL] [Abstract][Full Text] [Related]
3. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Med Hypotheses; 2007; 68(5):1108-13. PubMed ID: 17097823
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery.
Sauzeau V; Rolli-Derkinderen M; Lehoux S; Loirand G; Pacaud P
Circ Res; 2003 Oct; 93(7):630-7. PubMed ID: 12946946
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
6. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase is an important therapeutic target in cardiovascular medicine.
Shimokawa H; Takeshita A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
[TBL] [Abstract][Full Text] [Related]
9. Rho-kinase inhibition suppresses bladder hyperactivity in spontaneously hypertensive rats.
Rajasekaran M; Wilkes N; Kuntz S; E Albo M
Neurourol Urodyn; 2005; 24(3):295-300. PubMed ID: 15791631
[TBL] [Abstract][Full Text] [Related]
10. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells.
Nakakuki T; Ito M; Iwasaki H; Kureishi Y; Okamoto R; Moriki N; Kongo M; Kato S; Yamada N; Isaka N; Nakano T
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2088-93. PubMed ID: 16123329
[TBL] [Abstract][Full Text] [Related]
11. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.
Budzyn K; Marley PD; Sobey CG
Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997
[TBL] [Abstract][Full Text] [Related]
12. RhoA activation by hypoxia in pulmonary arterial smooth muscle cells is age and site specific.
Bailly K; Ridley AJ; Hall SM; Haworth SG
Circ Res; 2004 May; 94(10):1383-91. PubMed ID: 15087418
[TBL] [Abstract][Full Text] [Related]
13. RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights.
Jin L; Burnett AL
Clin Sci (Lond); 2006 Feb; 110(2):153-65. PubMed ID: 16411892
[TBL] [Abstract][Full Text] [Related]
14. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat.
Nagaoka T; Gebb SA; Karoor V; Homma N; Morris KG; McMurtry IF; Oka M
J Appl Physiol (1985); 2006 Mar; 100(3):996-1002. PubMed ID: 16322374
[TBL] [Abstract][Full Text] [Related]
15. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
[TBL] [Abstract][Full Text] [Related]
16. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P
Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation.
Löhn M; Steioff K; Bleich M; Busch AE; Ivashchenko Y
Eur J Pharmacol; 2005 Jan; 507(1-3):179-86. PubMed ID: 15659308
[TBL] [Abstract][Full Text] [Related]
18. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.
Abe K; Tawara S; Oi K; Hizume T; Uwatoku T; Fukumoto Y; Kaibuchi K; Shimokawa H
J Cardiovasc Pharmacol; 2006 Dec; 48(6):280-5. PubMed ID: 17204906
[TBL] [Abstract][Full Text] [Related]
19. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
20. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans.
Calò LA; Pessina AC
J Hypertens; 2007 Feb; 25(2):259-64. PubMed ID: 17211228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
